Welcome to chemicalbook!
+1 (818) 612-2111
RFQ
Try our best to find the right business for you.
Do not miss inquiry messages Please log in to view all inquiry messages.

Welcome back!

RFQ
skype
MY Account
Top
Postion:Product Catalog >TAK-779
TAK-779
  • TAK-779

TAK-779 NEW

Price $38 $89 $139
Package 1mg 5mg 10mg
Min. Order:
Supply Ability: 10g
Update Time: 2025-04-29

Product Details

Product Name: TAK-779 CAS No.: 229005-80-5
Purity: 99.21% Supply Ability: 10g
Release date: 2025/04/29

Product Introduction

Bioactivity

NameTAK-779
DescriptionTAK-779 (Takeda 779) is an antagonist of chemokine receptor 5 (CCR5), CCR2b, and CXC chemokine receptor 3 (CXCR3).
In vitroTAK-779 (250 mg/animal per day) inhibits ovalbumin-induced increases in CCR5, CXCR3, IFN-γ, and TNF-α expression in mouse lung, as well as the number of total cells, lymphocytes, and eosinophils in bronchoalveolar lavage fluid (BALF), in a mouse model of asthma[1].
In vivoTAK-779 increases intestinal allograft survival in a rat model of small intestine transplantation when administered at a dose of 10 mg/kg per day[2].
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility InformationH2O : 16.66 mg/mL (31.37 mM), Sonication is recommended.
DMSO : 25 mg/mL (47.07 mM), Sonication is recommended.
KeywordsTakeda-779 | Takeda779 | TAK-779 | TAK779 | TAK 779 | Inhibitor | inhibit | Human immunodeficiency virus | HIVProtease | HIV Protease | HIV | CXCR | CXC chemokine receptors | CCR2 | CCR | CC chemokine receptor
Inhibitors RelatedStavudine | 5-Fluorouracil | Emtricitabine | Kaempferol | Dolutegravir intermediate-1 | Tannic acid | Dextran sulfate sodium salt (MW 4500-5500) | Lamivudine | Chloroquine phosphate | Valproic Acid | Decanedioic acid | Tenofovir
Related Compound LibrariesBioactive Compound Library | Cytokine Inhibitor Library | Membrane Protein-targeted Compound Library | Anti-Viral Compound Library | Inhibitor Library | Immuno-Oncology Compound Library | Immunology/Inflammation Compound Library | Bioactive Compounds Library Max | Covalent Inhibitor Library | GPCR Compound Library | Anti-COVID-19 Compound Library | Anti-Cancer Compound Library

Company Profile Introduction

Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers. TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.

You may like

Recommended supplier

Product name Price   Suppliers Update time
$/
VIP5Y
RongNa Biotechnology Co.,Ltd
2025-04-29
$0.00/1g
VIP1Y
Xi an Biohorlden Industry Trade Co Ltd
2025-04-17
$80.00/1kg
VIP2Y
Zibo Hangyu Biotechnology Development Co., Ltd
2023-10-30
  • Since: 2011-01-07
  • Address: 36 Washington Street, Wellesley Hill, MA
INQUIRY